Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 21, 2007

Four Unique Gene Expression Profiles Found in Schizophrenia and Bipolar Patients

  • Curidium Medica  says it discovered the existence of four unique diagnostic gene expression profiles in blood samples from schizophrenia/bipolar disorder patients.

    The company used its Homomatrix tool to analyze 115 patients and matched controls. It found that each patient/control was a member of only one of four subgroups. Each subgroup was associated with a unique and finite number of genes. The genes identified in each subgroup include known and novel drug targets and biomarkers.

    The company is in the process of determining the specificity and sensitivity of a potential blood diagnostic test.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »